| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_765ae29e3ef4d92f8053f0f3e472ebc1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14a56e82e7ee8111cfcd7565412176b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35b802dd9ecbc521c1e49dfc8e99d7c7 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
| filingDate |
2004-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7567ebd03e7b3492b391135083fd5027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7edd48a75521973cfd85101357b343f |
| publicationDate |
2005-01-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005000830-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising cabbinochreme type compounds |
| abstract |
The invention relates to the use of cannabichromene type compounds and derivatives thereof in the treatment of mood disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3095452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017737-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2609928-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2609928-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8481085-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009087351-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2468828-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2468828-A |
| priorityDate |
2003-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |